Chan Jimmy J, Guzman Javier Z, Vargas Luilly, Myerson C Lucas, Chan Jesse, Vulcano Ettore
Orthopedics. 2018 Sep 1;41(5):e734-e737. doi: 10.3928/01477447-20180724-06. Epub 2018 Jul 27.
Eleven patients with symptomatic talus osteochondral defects who underwent subchondroplasty with bone marrow aspirate concentrate injection were retrospectively reviewed. Foot and Ankle Outcome Score and visual analog scale pain score were recorded preoperatively and at the 1-year postoperative visit. The mean osteochondral defect size was 1.3×1.4 cm. The weight-bearing visual analog scale pain score improved from a mean of 7.8 to 1.8, and the Foot and Ankle Outcome Score improved from a mean of 67.1 to 89.6. At 1-year follow-up, 10 patients reported they would have the procedure again. Subchondroplasty and bone marrow aspirate concentrate injection offered good pain relief for talus osteochondral defects. The procedure allows immediate weight bearing postoperatively and does not compromise future treatments. [Orthopedics. 2018; 41(5):e734-e737.].
对11例有症状的距骨骨软骨损伤患者进行了回顾性研究，这些患者接受了软骨下成形术并注射骨髓浓缩液。术前及术后1年随访时记录足踝结果评分和视觉模拟量表疼痛评分。骨软骨损伤的平均大小为1.3×1.4厘米。负重视觉模拟量表疼痛评分从平均7.8分改善至1.8分，足踝结果评分从平均67.1分提高到89.6分。在1年的随访中，10例患者表示愿意再次接受该手术。软骨下成形术和骨髓浓缩液注射为距骨骨软骨损伤提供了良好的疼痛缓解效果。该手术允许术后立即负重，且不影响未来的治疗。[《骨科》。2018；41(5):e734 - e737。]
